Exogenus Therapeutics CEO, Joana Simões Correia, participated in a roundtable organized by Cell & Gene Therapy Insights and Miltenyi, as part of a discussion panel about “Diagnostic & therapeutic uses for extracellular vesicles (EVs): insights into a rapidly evolving field”. The roundtable was shared with three key players in the Extracellular Vesicles field from academia and industry. In this round table, the experts presented their view about the major challenges of the translation of EVsinto the clinic, the next steps, and prospective future of clinical trials with EVs.

Joana Simões Correia commented: “It was a pleasure to participate in this roundtable to discuss the challenges and future perspectives of EVs therapeutics, together with other recognized experts in the field. With our current business model, focused on internal and collaborative technology and product development, Exogenus Therapeutics aims to foster this promising area of innovative therapeutics, providing our expertise in the field, to fast track EVs for clinical use.”

To find out more about the roundtable discussion click here.